144 related articles for article (PubMed ID: 17974975)
21. Clusterin and DNA repair: a new function in cancer for a key player in apoptosis and cell cycle control.
Shannan B; Seifert M; Boothman DA; Tilgen W; Reichrath J
J Mol Histol; 2006 Sep; 37(5-7):183-8. PubMed ID: 17048076
[TBL] [Abstract][Full Text] [Related]
22. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism.
Franzen CA; Amargo E; Todorović V; Desai BV; Huda S; Mirzoeva S; Chiu K; Grzybowski BA; Chew TL; Green KJ; Pelling JC
Cancer Prev Res (Phila); 2009 Sep; 2(9):830-41. PubMed ID: 19737984
[TBL] [Abstract][Full Text] [Related]
23. Clusterin is a short half-life, poly-ubiquitinated protein, which controls the fate of prostate cancer cells.
Rizzi F; Caccamo AE; Belloni L; Bettuzzi S
J Cell Physiol; 2009 May; 219(2):314-23. PubMed ID: 19137541
[TBL] [Abstract][Full Text] [Related]
24. CLU "in and out": looking for a link.
Pucci S; Mazzarelli P; Nucci C; Ricci F; Spagnoli LG
Adv Cancer Res; 2009; 105():93-113. PubMed ID: 19879425
[TBL] [Abstract][Full Text] [Related]
25. Novel nucleolar localization of clusterin and its associated functions in human oral cancers: An in vitro and in silico analysis.
Kadam R; Harish M; Dalvi K; Teni T
Cell Biochem Funct; 2021 Apr; 39(3):380-391. PubMed ID: 33155695
[TBL] [Abstract][Full Text] [Related]
26. Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.
Lenferink AE; Cantin C; Nantel A; Wang E; Durocher Y; Banville M; Paul-Roc B; Marcil A; Wilson MR; O'Connor-McCourt MD
Oncogene; 2010 Feb; 29(6):831-44. PubMed ID: 19935703
[TBL] [Abstract][Full Text] [Related]
27. Small interfering RNA targeted to secretory clusterin blocks tumor growth, motility, and invasion in breast cancer.
Niu Z; Li X; Hu B; Li R; Wang L; Wu L; Wang X
Acta Biochim Biophys Sin (Shanghai); 2012 Dec; 44(12):991-8. PubMed ID: 23099883
[TBL] [Abstract][Full Text] [Related]
28. Modulation of clusterin isoforms is associated with all-trans retinoic acid-induced proliferative arrest and apoptosis of intimal smooth muscle cells.
Orlandi A; Pucci S; Ciucci A; Pichiorri F; Ferlosio A; Spagnoli LG
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):348-53. PubMed ID: 15591223
[TBL] [Abstract][Full Text] [Related]
29. Detecting soluble clusterin in in-vitro and in-vivo models of prostate cancer.
Girard FP; Byrne J; Downes M; Fanning D; Desgrandchamps F; Fitzpatrick JM; Watson RW
Neoplasma; 2010; 57(5):488-93. PubMed ID: 20568904
[TBL] [Abstract][Full Text] [Related]
30. Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cells.
Zhong B; Sallman DA; Gilvary DL; Pernazza D; Sahakian E; Fritz D; Cheng JQ; Trougakos I; Wei S; Djeu JY
Mol Cancer Ther; 2010 Jun; 9(6):1831-41. PubMed ID: 20501799
[TBL] [Abstract][Full Text] [Related]
31. Intracellular signaling cascades triggered by the NK1 fragment of hepatocyte growth factor in human prostate epithelial cell line PNT1A.
Pavone LM; Cattaneo F; Rea S; De Pasquale V; Spina A; Sauchelli E; Mastellone V; Ammendola R
Cell Signal; 2011 Dec; 23(12):1961-71. PubMed ID: 21777671
[TBL] [Abstract][Full Text] [Related]
32. The leader sequence triggers and enhances several functions of clusterin and is instrumental in the progression of human prostate cancer in vivo and in vitro.
Zhang Q; Zhou W; Kundu S; Jang TL; Yang X; Pins M; Smith N; Jovanovic B; Xin D; Liang L; Guo Y; Lee C
BJU Int; 2006 Aug; 98(2):452-60. PubMed ID: 16879694
[TBL] [Abstract][Full Text] [Related]
33. Interaction of a putative BH3 domain of clusterin with anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy.
Lee DH; Ha JH; Kim Y; Bae KH; Park JY; Choi WS; Yoon HS; Park SG; Park BC; Yi GS; Chi SW
Biochem Biophys Res Commun; 2011 May; 408(4):541-7. PubMed ID: 21527247
[TBL] [Abstract][Full Text] [Related]
34. Distinct promoters, subjected to epigenetic regulation, drive the expression of two clusterin mRNAs in prostate cancer cells.
Bonacini M; Coletta M; Ramazzina I; Naponelli V; Modernelli A; Davalli P; Bettuzzi S; Rizzi F
Biochim Biophys Acta; 2015 Jan; 1849(1):44-54. PubMed ID: 25464035
[TBL] [Abstract][Full Text] [Related]
35. The role of clusterin (CLU) in malignant transformation and drug resistance in breast carcinomas.
Redondo M; Tellez T; Roldan MJ
Adv Cancer Res; 2009; 105():21-43. PubMed ID: 19879421
[TBL] [Abstract][Full Text] [Related]
36. Transcriptomes of Clusterin- and S100B-transfected neuronal cells elucidate protective mechanisms against hypoxia and oxidative stress in the hooded seal (Cystophora cristata) brain.
Martens GA; Geßner C; Osterhof C; Hankeln T; Burmester T
BMC Neurosci; 2022 Oct; 23(1):59. PubMed ID: 36243678
[TBL] [Abstract][Full Text] [Related]
37. The chaperone activity of clusterin is dependent on glycosylation and redox environment.
Rohne P; Prochnow H; Wolf S; Renner B; Koch-Brandt C
Cell Physiol Biochem; 2014; 34(5):1626-39. PubMed ID: 25402950
[TBL] [Abstract][Full Text] [Related]
38. Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cells.
Zoubeidi A; Ettinger S; Beraldi E; Hadaschik B; Zardan A; Klomp LW; Nelson CC; Rennie PS; Gleave ME
Mol Cancer Res; 2010 Jan; 8(1):119-30. PubMed ID: 20068069
[TBL] [Abstract][Full Text] [Related]
39. Alpha-actinin 1 and alpha-actinin 4: contrasting roles in the survival, motility, and RhoA signaling of astrocytoma cells.
Quick Q; Skalli O
Exp Cell Res; 2010 Apr; 316(7):1137-47. PubMed ID: 20156433
[TBL] [Abstract][Full Text] [Related]
40. Clusterin, a Novel DEC1 Target, Modulates DNA Damage-Mediated Cell Death.
Ming X; Bao C; Hong T; Yang Y; Chen X; Jung YS; Qian Y
Mol Cancer Res; 2018 Nov; 16(11):1641-1651. PubMed ID: 30002194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
